A study of more than 12,000 Finnish babies found that those who were given inhaled corticosteroids during the first 2 years of life were too short for their age.
The FDA has approved the use of ambrisentan (Letairis) in combination with tadalafil (Cialis) as up-front therapy for pulmonary arterial hypertension (PAH) to reduce the risk of worsening disease and improve exercise ability.
Surgery considerably improved quality of life among patients with chronic rhinosinusitis and comorbid obstructive sleep apnea, according to study results.
Focus Diagnostics’ influenza and RSV molecular test has been cleared for an additional 46 influenza A and influenza B strains and seven additional RSV strains.
As a result of two studies showing the efficacy of atezolizumab, Martin Reck, MD, says the antibody can change treatment strategies for refractory lung cancer.
Researchers at Harvard University have found that smokers with COPD may face nearly twice the risk of getting small cell lung cancer (SCLC) than those without the disease.
A large study suggests breathing in tiny particles of toxic chemicals from the air could lead to an increased risk of premature death, according to HealthDay.
A research study aimed to see if the CyPath test could complement CT screening as a technique for detecting early stage lung cancer.
Boehringer Ingelheim announces that the results of OTEMTO 1 & 2 reinforce the benefits of Spiolto Respimat as first line maintenance therapy for COPD.
According to Novavax, study data show that immunizing pregnant women with its RSV vaccine is safe and can protect infants against the virus.
Aradigm has announced the completion of patient enrollment for ORBIT-4, a clinical trial of Pulmaquin for non-cystic fibrosis bronchiectasis.
There is insufficient awareness of the health risks caused by the inhalation of talc, and this lack of awareness needs to be addressed urgently, according to research presented at ERS 2015.
Teva Pharmaceuticals has announced it will acquire Gecko Health Innovations, a smart inhaler company.
A new study reveals that the reason candidate vaccines for H7N9 influenza have failed to elicit strong immune responses may be due to immune camouflage.
Keytruda (pembrolizumab, Merck & Co) was just FDA-approved to treat patients with advanced (metastatic) NSCLC with tumors that express a protein called PD-L1, according to an agency news release.
A vitamin D deficiency may speed the progression of COPD, according to research.
Researchers show that pre- and post-natal exposure to tobacco is associated with a risk of behavioral disorders in children.
Lung transplant patients in Europe who live near busy roads with high air pollution are more likely to experience chronic organ rejection or die, according to new research.
The retired chairman and CEO of Hasbro will donate $12.5 million to Brown University to create an institute devoted to combating childhood asthma, autism, and obesity.
GlaxoSmithKline and Theravance have announced their intent to file a new drug application in Japan for Relvar Ellipta, a combination inhaler for COPD.